Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: A systematic review and meta-analysis

Gynecologic Oncology

Volumn 134, Issue 1, 2014, Pages 166-171

  Petrelli, Fausto ^a   De Stefani, Agostina ^a   Raspagliesi, Francesco ^b   Lorusso, Domenica ^b   Barni, Sandro ^a  

^a TREVIGLIO HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervical cancer; Chemoradiotherapy; Cisplatin; Combination chemotherapy; Overall survival

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; GEMCITABINE; PACLITAXEL; BEVACIZUMAB; DOCETAXEL;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CONSOLIDATION CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; DISTANT METASTASIS; EMBASE; HUMAN; MEDLINE; META ANALYSIS; OVERALL SURVIVAL; PELVIS LYMPH NODE; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; ADVANCED CANCER; ANEMIA; ATTRIBUTABLE RISK; CANCER RECURRENCE; CANCER STAGING; COCHRANE LIBRARY; COMBINATION CHEMOTHERAPY; DIARRHEA; DISSECTION; HEALTH CARE QUALITY; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; PARAAORTIC LYMPH NODE; RADICAL HYSTERECTOMY; RECURRENCE RISK; SCOPUS; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING; WEB OF SCIENCE;

CERVICAL CANCER; CHEMORADIOTHERAPY; CISPLATIN; COMBINATION CHEMOTHERAPY; OVERALL SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE CERVICAL NEOPLASMS;

EID: 84903192859     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.04.049     Document Type: Review

References (25)

1. P.J. Eifel Concurrent chemotherapy and radiation: a major advance for women with cervical cancer J Clin Oncol 17 1999 1334
2. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs 3rd et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154
3. W.A. Peters 3rd, P.Y. Liu, R.J. Barrett 2nd, R.J. Stock, B.J. Monk, and J.S. Berek et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606
4. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144
5. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Jr et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339
6. P.J. Eifel Chemoradiation for carcinoma of the cervix: Advances and opportunities Radiat Res 154 2000 229
7. P.G. Rose, S. Ali, E. Watkins, J.T. Thigpen, G. Deppe, and D.L. Clarke-Pearson et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 19 Jul 1 2007 2804 2810 (Pubitemid 47123190)
8. A. Dueñas-González, J.J. Zarbá, F. Patel, J.C. Alcedo, S. Beslija, and L. Casanova et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix, J Clin Oncol 29 13 May 1 2011 1678 1685
9. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336 341
10. G.A. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, and M. Losos et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available: http://www.ohri.ca/programs/ clinicalepidemiology/oxford.asp [Last accessed: 2014 February 9th]
11. Y.Y. Lee, W. Park, S.J. Huh, A. Yoon, J.Y. Park, and C.H. Choi et al. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis Anticancer Res 33 10 Oct 2013 4675 4681 [PubMed PMID: 24123048]
12. E.D. Donnelly, T. Refaat, M. Gentile, A. Herskovic, J. Boyle, and I. Helenowski et al. Evaluation of outcomes in patients with carcinoma of the cervix treated with concurrent radiation and cisplatin versus cisplatin/5-FU compared with radiation alone Am J Clin Oncol Jul 24 2013 [[Epub ahead of print] PubMed PMID: 24022364]
13. J. Nedovic, Z. Protrka, S. Ninkovic, S. Mitrovic, R. Vojinovic, and J. Glisic et al. Cisplatin monotherapy with concurrent radiotherapy versus combination of cisplatin and 5-fluorouracil chemotherapy with concurrent radiotherapy in patients with locoregionally advanced cervical carcinoma J BUON 17 4 Oct-Dec 2012 740 745 [PubMed PMID: 23335535]
14. J. Pu, S.S. Qin, J.X. Ding, Y. Zhang, W.G. Zhu, and C.H. Yu et al. A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery J Cancer Res Clin Oncol 139 4 Apr 2013 703 708 10.1007/s00432-013-1373-9 [Epub 2013 Jan 18. PubMed PMID: 23328996]
15. T.W. Kong, S.J. Chang, J. Paek, S.C. Yoo, J.H. Yoon, and K.H. Chang et al. Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer J Gynecol Oncol 23 4 Oct 2012 235 241 10.3802/jgo.2012.23.4.235 [Epub 2012 Sep 19. PubMed PMID: 23094126; PubMed Central PMCID: PMC3469858]
16. Y.S. Kim, S.S. Shin, J.H. Nam, Y.T. Kim, Y.M. Kim, and J.H. Kim et al. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer Gynecol Oncol 108 1 Jan 2008 195 200 [Epub 2007 Oct 25. PubMed PMID: 17963825] (Pubitemid 350299446)
17. M.A. Torres, A. Jhingran, H.D. Thames Jr., C.F. Levenback, D.C. Bodurka, and L.M. Ramondetta et al. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment Int J Radiat Oncol Biol Phys 70 1 Jan 1 2008 118 125 [Epub 2007 Sep 14. PubMed PMID: 17869451] (Pubitemid 350251023)
18. A. Dueñas-González, L. Cetina-Perez, C. Lopez-Graniel, A. Gonzalez-Enciso, E. Gómez-Gonzalez, and L. Rivera-Rubi et al. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized phase II study Int J Radiat Oncol Biol Phys 61 3 Mar 1 2005 817 823 (Pubitemid 40247977)
19. http://www.nccn.org/professionals/physician-gls/pdf/cervical.pdf [last accessed 2014, February 15th]
20. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143 (Pubitemid 29177872)
21. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
22. T. Schefter, K. Winter, J.S. Kwon, K. Stuhr, K. Balaraj, and B.P. Yaremko et al. Radiation Therapy Oncology Group (RTOG). RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma Int J Radiat Oncol Biol Phys 88 1 Jan 1 2014 101 105
23. P.A. Disilvestro, S. Ali, P.S. Craighead, J.A. Lucci, Y.C. Lee, and D.E. Cohn et al. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study J Clin Oncol 32 5 Feb 10 2014 458 464
24. V. Oppedijk, A. van der Gaast, J.J. van Lanschot, P. van Hagen, R. van Os, and C.M. van Rij et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials J Clin Oncol 32 5 Feb 10 2014 385 391
25. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 9034 Oct 19 1996 1049 1054